Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · March 23, 2024

Interim Estimates of 2023–2024 Seasonal Influenza Vaccine Effectiveness in the US

MMWR. Morbidity and Mortality Weekly Report


Additional Info

Disclosure statements are available on the authors' profiles:

MMWR. Morbidity and Mortality Weekly Report
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States
MMWR Morb. Mortal. Wkly. Rep. 2024 Feb 29;73(8)168-174, AM Frutos, AM Price, E Harker, EL Reeves, HM Ahmad, V Murugan, ET Martin, S House, EA Saade, RK Zimmerman, M Gaglani, KJ Wernli, EB Walter, MG Michaels, MA Staat, GA Weinberg, R Selvarangan, JA Boom, EJ Klein, NB Halasa, AA Ginde, KW Gibbs, Y Zhu, WH Self, SY Tartof, NP Klein, K Dascomb, MB DeSilva, ZA Weber, DH Yang, SW Ball, D Surie, J DeCuir, FS Dawood, HL Moline, AP Toepfer, BR Clopper, R Link-Gelles, AB Payne, JR Chung, B Flannery, NM Lewis, SM Olson, K Adams, MW Tenforde, S Garg, LA Grohskopf, C Reed, S Ellington

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading